Stephen V. Faraone, PhD
a:1:{i:0;s:113:"Departments of Psychiatry and of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, New York";}
Original Research
Efficacy and Safety of AR19 in Adults With ADHD
August 24, 2021
Misuse of stimulant medications prescribed for attention-deficit/hyperactivity disorder (ADHD) can have adverse medical outcomes. This study tested the safety and efficacy of AR19, a manipulation-resistant formulation of amphetamine, in...
Insights
AR19, a Manipulation-Resistant Formulation of Amphetamine Sulfate, in Adult ADHD
August 24, 2021
AR19, a manipulation-resistant formulation of amphetamine sulfate, was created to address the problem of non-oral use of stimulant medications (eg, smoking, injecting). In this video, Dr Faraone highlights the...
Original Research
Lisdexamfetamine for Sluggish Cognitive Tempo and Adult ADHD
June 29, 2021
Many patients with ADHD have “sluggish cognitive tempo,” characterized by daydreaming, being underactive, and feeling spacey and lethargic. This RCT evaluated the use of lisdexamfetamine in adults to reduce...
Original Research
Predictors of the Persistence and Emergence of ADHD Over a 9-Year Period
May 7, 2019
What factors may predict the onset of ADHD in adolescence? This population-based study used baseline and follow-up phone interviews to identify predictors and evaluate the validity of subthreshold and...
